Skip to main content

and
  1. Article

    Open Access

    Author Correction: Using mortuary and burial data to place COVID-19 in Lusaka, Zambia within a global context

    Richard J. Sheppard, Oliver J. Watson, Rachel Pieciak, James Lungu in Nature Communications (2024)

  2. Article

    Open Access

    Author Correction: A repeated cross-sectional analysis on the economic impact of SARS-CoV-2 pandemic at the hospital level in Italy

    Filippo Trentini, Oriana Ciani, Elena Vanni, Simone Ghislandi in Scientific Reports (2023)

  3. Article

    Open Access

    A repeated cross-sectional analysis on the economic impact of SARS-CoV-2 pandemic at the hospital level in Italy

    Italy was the first country in Europe to be hit by the Severe Acute Respiratory Syndrome Coronavirus 2. Little research has been conducted to understand the economic impact of providing care for SARS-CoV-2 pat...

    Filippo Trentini, Oriana Ciani, Elena Vanni, Simone Ghislandi in Scientific Reports (2023)

  4. Article

    Open Access

    Using mortuary and burial data to place COVID-19 in Lusaka, Zambia within a global context

    Reported COVID-19 cases and associated mortality remain low in many sub-Saharan countries relative to global averages, but true impact is difficult to estimate given limitations around surveillance and mortali...

    Richard J. Sheppard, Oliver J. Watson, Rachel Pieciak, James Lungu in Nature Communications (2023)

  5. Article

    Open Access

    Individual’s daily behaviour and intergenerational mixing in different social contexts of Kenya

    We investigated contact patterns in diverse social contexts in Kenya and the daily behaviours that may play a pivotal role in infection transmission to the most vulnerable leveraging novel data from a 2-day su...

    Emanuele Del Fava, Irene Adema, Moses C. Kiti, Piero Poletti in Scientific Reports (2021)

  6. Article

    Open Access

    National interest may require distributing COVID-19 vaccines to other countries

    As immunization campaigns are accelerating, understanding how to distribute the scarce doses of vaccines is of paramount importance and a quantitative analysis of the trade-offs involved in domestic-only versu...

    Tiziano Rotesi, Paolo Pin, Maria Cucciniello, Amyn A. Malik in Scientific Reports (2021)

  7. Article

    Public opinion on global rollout of COVID-19 vaccines

    Philip M. Clarke, Laurence S. J. Roope, Peter John Loewen in Nature Medicine (2021)

  8. Article

    Open Access

    Modeling the interplay between demography, social contact patterns, and SARS-CoV-2 transmission in the South West Shewa Zone of Oromia Region, Ethiopia

    COVID-19 spread may have a dramatic impact in countries with vulnerable economies and limited availability of, and access to, healthcare resources and infrastructures. However, in sub-Saharan Africa, a low pre...

    Filippo Trentini, Giorgio Guzzetta, Margherita Galli, Agnese Zardini in BMC Medicine (2021)

  9. Article

    Open Access

    The introduction of ‘No jab, No school’ policy and the refinement of measles immunisation strategies in high-income countries

    In recent years, we witnessed a resurgence of measles even in countries where, according to WHO guidelines, elimination should have already been achieved. In high-income countries, the raise of anti-vaccinatio...

    Filippo Trentini, Piero Poletti, Alessia Melegaro, Stefano Merler in BMC Medicine (2019)

  10. Article

    Open Access

    The potential impact of the demographic transition in the Senegal-Gambia region of sub-Saharan Africa on the burden of infectious disease and its potential synergies with control programmes: the case of hepatitis B

    Sub-Saharan Africa (SSA) continues to suffer high communicable disease burdens as its demographic transition (DT) proceeds. Although the consequent changes in population structures influence age-specific conta...

    John R. Williams, Piero Manfredi, Alessia Melegaro in BMC Medicine (2018)

  11. Article

    Open Access

    The impact of demographic changes, exogenous boosting and new vaccination policies on varicella and herpes zoster in Italy: a modelling and cost-effectiveness study

    The present study aims to evaluate the cost-effectiveness of the newly introduced varicella and herpes zoster (HZ) vaccination programmes in Italy. The appropriateness of the introduction of the varicella vacc...

    Alessia Melegaro, Valentina Marziano, Emanuele Del Fava, Piero Poletti in BMC Medicine (2018)

  12. Article

    Open Access

    Evaluating vaccination strategies for reducing infant respiratory syncytial virus infection in low-income settings

    Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract disease and related hospitalization of young children in least developed countries. Individuals are repeatedly infected, but it i...

    Piero Poletti, Stefano Merler, Marco Ajelli, Piero Manfredi in BMC Medicine (2015)

  13. Article

    Open Access

    The role of different social contexts in sha** influenza transmission during the 2009 pandemic

    Evaluating the relative importance of different social contexts in which infection transmission occurs is critical for identifying optimal intervention strategies. Nonetheless, an overall picture of influenza ...

    Marco Ajelli, Piero Poletti, Alessia Melegaro, Stefano Merler in Scientific Reports (2014)

  14. Article

    Open Access

    Cost effectiveness of pediatric pneumococcal conjugate vaccines: a comparative assessment of decision-making tools

    Several decision support tools have been developed to aid policymaking regarding the adoption of pneumococcal conjugate vaccine (PCV) into national pediatric immunization programs. The lack of critical apprais...

    Nathorn Chaiyakunapruk, Ratchadaporn Somkrua, Raymond Hutubessy in BMC Medicine (2011)

  15. Article

    Open Access

    Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease

    The 7-valent pneumococcal conjugate vaccine has been introduced in national immunisation programmes of most industrialised countries and recently in two African GAVI eligible countries (Rwanda and The Gambia)....

    Alessia Melegaro, Yoon Hong Choi, Robert George, W John Edmunds in BMC Infectious Diseases (2010)

  16. No Access

    Article

    The 23-Valent Pneumococcal Polysaccharide Vaccine. Part II. A Cost-Effectiveness Analysis for Invasive Disease in the Elderly in England and Wales

    The 23-valent pneumococcal polysaccharide vaccine (PPV) has been available for a number of years and is recommended for high-risk categories. Relatively immunocompetent elderly people are not included in this ...

    Alessia Melegaro, W. John Edmunds in European Journal of Epidemiology (2004)

  17. No Access

    Article

    The 23-Valent Pneumococcal Polysaccharide Vaccine. Part I. Efficacy of PPV in the Elderly: A Comparison of Meta-Analyses

    A 23-valent polysaccharide pneumococcal vaccine (PPV) has been available in the UK for more than 20 years and is currently recommended for use in high-risk groups (HRG) of 2+ years of age. The degree of protec...

    Alessia Melegaro, W. John Edmunds in European Journal of Epidemiology (2004)